Editas Medicine, Inc. (NASDAQ:EDIT) Q3 2023 Earnings Conference Call November 3, 2023 8:00 AM ET
Company Participants
Cristi Barnett - Corporate Communications & IR
Gilmore O'Neill - CEO
Baisong Mei - CMO
Erick Lucera - CFO
Linda Burkly - CSO
Caren Deardorf - Chief Commercial & Strategy Officer
Conference Call Participants
Brian Cheng - J.P. Morgan
Samantha Semenkow - Citi
Joon Lee - Truist Securities
Greg Harrison - Bank of America
Gena Wang - Barclays
Jack Allen - Baird
Dae Gon Ha - Stifel
Phil Nadeau - TD Cowen
Yanan Zhu - Wells Fargo
Eric Schmidt - Cantor Fitzgerald
Steve Seedhouse - Raymond James
Luca Issi - RBC
Jay Olson - Oppenheimer
Jingming Chen - Evercore ISI
Lili Nsongo - Leerink
Operator
Good morning, and welcome to Editas Medicine's Third Quarter Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Cristi Barnett, Corporate Communications and Investor Relations at Editas Medicine.
Cristi Barnett
Thank you, Rob. Good morning, everyone, and welcome to our third quarter 2023 conference call.
Earlier this morning, we issued a press release providing our financial results and recent corporate updates. A replay of today's call will be available in the Investors section of our website approximately two hours after its completion. After our prepared remarks, we will open the call for Q&A.
As a reminder, various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our most recent Annual Report on Form 10-K, which is on file with the SEC as updated by our subsequent filings.
In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. Except as required by law, we specifically disclaim any obligation to update or revise any forward-looking statements, even if our views change.
Now, I will turn the call over to our CEO, Gilmore O'Neill.
Gilmore O'Neill